Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2001;7(5):432–436. doi: 10.1080/135502801753170282

Sequence analysis of the S gene of recombinant MHV-2/A59 coronaviruses reveals three candidate mutations associated with demyelination and hepatitis

Jayasri Das Sarma 1, Li Fu 1, Susan T Hingley 2, Michael M C Lai 3, Ehud Lavi 1,✉
PMCID: PMC7095204  PMID: 11582515

Abstract

Coronaviruses, mouse hepatitis virus (MHV) strains, exhibit various degrees of neurotropism and hepatotropism following intracerebral (IC) infection of 4-week-old C57Bl/6 mice. Whereas MHV-A59 produces acute meningitis, encephalitis, hepatitis, and chronic demyelination, a closely related strain, MHV-2, produces only acute meningitis and hepatitis. We previously reported that the spike glycoprotein gene of MHV contains determinants of demyelination and hepatitis. To further investigate the site of demyelination and hepatitis determinants within the S gene, we sequenced the S gene of several nonde-myelinating recombinant viruses. We found that three encephalitis-positive, demyelination-negative, hepatitis-negative recombinant viruses have an MHV-A59-derived S gene, which contains three identical point mutations (I375M, L652I, and T1087N). One or more of the sites of these mutations in the MHV-A59 genome are likely to contribute to demyelination and hepatitis.

Keywords: coronavirus, nidoviruses, mouse hepatitis virus (MHN), demyelination, hepatitis, multiple sclerosis (MS)

References

  1. Buchmeier MJ, Lewicki HA, Talbot PJ, Knobler RL. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology. 1984;132:261–270. doi: 10.1016/0042-6822(84)90033-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cavanagh D. Nidovirales: A new order comprising Coronaviridae and Arteriviridae. Arch Virol. 1997;142:629–633. [PubMed] [Google Scholar]
  3. Collins AR, Knobler RL, Powell H, Buchmeier MJ. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology. 1982;119:358–371. doi: 10.1016/0042-6822(82)90095-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dalziel RG, Lampert PW, Talbot PJ, Buchmeier MJ. Site specific alteration of murine hepatitis virus type 4 peplomer glycoprotein S results in reduced neurovirulence. J Virol. 1986;59:463–471. doi: 10.1128/jvi.59.2.463-471.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Das Sarma J, Fu L, Hingley ST, Lavi E. Mouse hepatitis virus type-2 infection in mice: An experimental model system of acute meningitis and hepatitis. Exp Mol Pathol. 2001;71:1–12. doi: 10.1006/exmp.2001.2378. [DOI] [PubMed] [Google Scholar]
  6. Das Sarma J, Fu L, Tsai JC, Weiss SR, Lavi E. Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus. J Virol. 2000;74:9206–9213. doi: 10.1128/JVI.74.19.9206-9213.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fleming JO, Shubin RA, Sussman MA, Casteel N, Stohlman SA. Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology. 1989;168:162–167. doi: 10.1016/0042-6822(89)90415-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gallagher TM, Escarmis C, Buchmeier MJ. Alteration of the pH dependence of coronavirus-induced cell fusion: Effect of mutations in the spike glycoprotein. J Virol. 1991;65:1916–1928. doi: 10.1128/jvi.65.4.1916-1928.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hingley ST, Gombold JL, Lavi E, Weiss SR. MHV-A59 fusion mutants are attenuated and display altered hepatotropism. Virology. 1994;200:1–10. doi: 10.1006/viro.1994.1156. [DOI] [PubMed] [Google Scholar]
  10. Hirano N, Fujiwara K, Hino S, Matumoto M. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch Ges Virusfors. 1974;44:298–302. doi: 10.1007/BF01240618. [DOI] [PubMed] [Google Scholar]
  11. Hirano N, Murakami T, Taguchi F, Fujiwara K, Matumoto M. Comparison of mouse hepatitis virus strains for pathogenicity in weanling mice infected by various routes. Arch Virol. 1981;70:69–73. doi: 10.1007/BF01320795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Houtman JJ, Fleming JO. Pathogenesis of mouse hepatitis virus-induced demyelination. J Neuro Virol. 1996;2:361–376. doi: 10.3109/13550289609146902. [DOI] [PubMed] [Google Scholar]
  13. Keck JG, Soe LH, Makino S, Stohlman SA, Lai MMC. RNA recombination of murine coronavirus: Recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2. J Virol. 1988;62:1989–1998. doi: 10.1128/jvi.62.6.1989-1998.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Knobler RL, Haspel MV, Oldstone MBA. Mouse hepatitis virus type 4 (JHM strain)-induced fatal central nervous system disease, part 1 (genetic control and the murine neurone as the susceptible site for disease) J Exp Med. 1981;153:832–843. doi: 10.1084/jem.153.4.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Knobler RL, Tunison LA, Lampert PW, Oldstone MBA. Selected mutants of mouse hepatitis virus type 4 (JHM strain) induce different CNS diseases. Pathobiology of disease induced by wild type and mutants ts8 and ts15 in BALB/c and SJL/J mice. Am J Pathol. 1982;109:157–168. [PMC free article] [PubMed] [Google Scholar]
  16. Lai MMC, Cavanagh D. The molecular biology of coronaviruses. Adv Virus Res. 1997;48:1–100. doi: 10.1016/S0065-3527(08)60286-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Laude H, Gelfi J, Lavenant L, Charley B. Single amino acid changes in the viral glycoprotein M affect induction of interferon by the coronavirus transmissible gastroenteritis virus. J Virol. 1992;66:743–749. doi: 10.1128/jvi.66.2.743-749.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lavi E, Fishman SP, Highkin MK, Weiss SR. Limbic encephalitis following inhalation of murine coronavirus MHV-A59. Lab Invest. 1988;58:31–36. [PubMed] [Google Scholar]
  19. Lavi E, Gilden DH, Highkin MK, Weiss SR. The organ tropism of mouse hepatitis virus A59 is dependent on dose and route of inoculation. Lab Anim Sci. 1986;36:130–135. [PubMed] [Google Scholar]
  20. Lavi E, Gilden DH, Wroblewska Z, Rorke LB, Weiss SR. Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology. 1984;34:597–603. doi: 10.1212/wnl.34.5.597. [DOI] [PubMed] [Google Scholar]
  21. Lavi E, Haluskey JA, Masters PS. Targeted recombination between MHV-2 and MHV-A59 to study neurotropic determinants of MHV. Adv Exp Med Biol. 1998;440:543–547. doi: 10.1007/978-1-4615-5331-1_70. [DOI] [PubMed] [Google Scholar]
  22. Lavi E, Kuo L, Haluskey JA, Masters PS. The pathogenesis of MHV nucleocapsid gene chimeric viruses. Adv Exp Med Biol. 1998;440:537–541. doi: 10.1007/978-1-4615-5331-1_69. [DOI] [PubMed] [Google Scholar]
  23. Lavi E, Murray EM, Makino S, Stohlman SA, Lai MM, Weiss SR. Determinants of coronavirus MHV pathogenesis are localized to 3′ portions of the genome as determined by ribonucleic acid-ribonucleic acid recombination. Lab Invest. 1990;62:570–578. [PubMed] [Google Scholar]
  24. Lavi E, Schwartz T, Jin YP, Fu L. Nidovirus infections: Experimental model systems of human neurologic diseases. J Neuropathol Exp Neurol. 1999;58:1197–1206. doi: 10.1097/00005072-199912000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lavi E, Weiss SR. Coronaviruses. In: Gilden DH, Lipton HL, editors. Clinical and molecular aspects of neurotropic viral infections. Boston, Massachusetts: Kluwer Academic Publishers; 1989. pp. 101–139. [Google Scholar]
  26. Leparc-Goffart I, Hingley ST, Chua M-M, Jiang X, Lavi E, Weiss SR. Altered pathogenesis phenotypes of murine coronavirus MHV-A59 are associated with a Q159L amino acid substitution in the receptor binding domain of the spike protein. Virology. 1997;239:1–10. doi: 10.1006/viro.1997.8877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Leparc-Goffart I, Hingley ST, Chua MM, Phillips J, Lavi E, Weiss SR. Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. J Virol. 1998;72:9628–9636. doi: 10.1128/jvi.72.12.9628-9636.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Navas S, Seo S, Chua MM, Das Sarma J, Lavi E, Hingley ST, Weiss SR. The spike protein of murine coronavirus determines the ability of the virus to replicate in the liver and cause hepatitis. J Virol. 2001;75:2452–2457. doi: 10.1128/JVI.75.5.2452-2457.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Perlman S, Jacobsen G, Olson AL, Afifi A. Identification of the spinal cord as a major site of persistence during chronic infection with a murine coronavirus. Virology. 1990;175:418–426. doi: 10.1016/0042-6822(90)90426-R. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Phillips JJ, Chua MM, Lavi E, Weiss SR. Pathogenesis of chimeric MHV-4/MHV-A59 recombinant viruses: The murine coronavirus spike protein is a major determinant of neurovirulence. J Virol. 1999;73:7752–7760. doi: 10.1128/jvi.73.9.7752-7760.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Reed L, Muench H. A simple method of estimating fifty percent end points. Am J Hyg. 1938;27:493–497. [Google Scholar]
  32. Wege H, Siddell S, ter Meulen V. The biology and pathogenesis of coronaviruses. Adv Virol Immunol. 1982;99:165–200. doi: 10.1007/978-3-642-68528-6_5. [DOI] [PubMed] [Google Scholar]
  33. Wege H, Stephenson JR, Koga M, Wege H, ter Meulen V. Genetic variation of neurotropic and non-neurotropic murine coronaviruses. J Gen Virol. 1981;54:67–74. doi: 10.1099/0022-1317-54-1-67. [DOI] [PubMed] [Google Scholar]
  34. Weiner LP. Pathogenesis of demyelination induced by a mouse hepatitis virus (JHM virus) Arch Neurol. 1973;28:298–303. doi: 10.1001/archneur.1973.00490230034003. [DOI] [PubMed] [Google Scholar]
  35. Yamada YK, Takimoto K, Yabe M, Taguchi F. Acquired fusion activity of a murine coronavirus MHV-2 variant with mutations in the proteolytic cleavage site and the siganal sequence of the S protein. Virology. 1997;227:215–219. doi: 10.1006/viro.1996.8313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Yokomori K, Banner LR, Lai MC. Heteroginity of gene expression of the hemagglutinin-esterase (HE) protein of murine coronaviruses. Virology. 1991;183:647–657. doi: 10.1016/0042-6822(91)90994-M. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurovirology are provided here courtesy of Nature Publishing Group

RESOURCES